High exposure to antibiotics in the population and differences by sex and age;Alta exposición a antibióticos en la población y sus diferencias por género y edad

Atencion Primaria

Volumn 43, Issue 5, 2011, Pages 236-244

  Catalina Serna, M ^a,b   Ribes, Esther ^e   Real, Jordi ^a,c   Galván, Leonardo ^e   Gascó, Eduardo ^d   Godoy, Pere ^e  

^a UNIVERSITY OF LLEIDA   (Spain)

^b ICS   (Spain)

^c Instituto de Investigación en Atención Primaria IDIAP Jordi Gol   (Spain)

^d Centro de Salud Ronda   (Spain)

^e Plan Director de las Enfermedades Reumáticas y del Aparato Locomotor   (Spain)

Author keywords

Antibiotics; Consumption; Drug use

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; CHILD; DRUG UTILIZATION; FEMALE; GROUPS BY AGE; HUMAN; MALE; OBSERVATIONAL STUDY; POPULATION EXPOSURE; PRESCHOOL CHILD; PRESCRIPTION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPAIN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 79955584654     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1016/j.aprim.2010.04.015     Document Type: Article

References (20)

1. Tenover FC, Hughes JM. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA. 1996;275:300-4.
2. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8:278-82. (Pubitemid 34266265)
3. Bjerrum L, Boada A, Cots JM, Llor C, Fores GD, Gahrn-Hansen B, et al. Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain. Eur J Clin Pharmacol. 2004;60:23-8. (Pubitemid 38471454)
4. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother. 2006;58:401-7. (Pubitemid 44294954)
5. WHO Collaborating Centre for Drugs Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification index including defined daily doses (DDDs) for plain substances. Oslo: WHO CCKSM. 1999.
6. Deschepper R, Vander Stichele RH, Haaijer-Ruskamp FM. Cross-cultural differences in lay attitudes and utilisation of antibiotics in a Belgian and a Dutch city. Patient Educ Couns. 2002;48:161-9. (Pubitemid 36158878)
7. Goossens H, Ferech M, Coenen S, Stephens P. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007;44:1091-5.
8. Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ. 2002;324:91-4. (Pubitemid 34073141)
9. Coenen S, Ferech M, Haaijer-Ruskamp FM, Butler CC, Vander Stichele RH, Verheij TJ, et al. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care. 2007;16:440-5.
10. Caminal J, Rovira J. Antibiotic prescription in primary health care: clinical and economic perspectives (Catalonia, Spain). Eur J Public Health. 2005;15:276-81. (Pubitemid 41399556)
11. Jelinski S, Parfrey P, Hutchinson J. Antibiotic utilisation in community practices: guideline concurrence and prescription necessity. Pharmacoepidemiol Drug Saf. 2005;14:319-26. (Pubitemid 40716324)
12. Goldman RD, Scolnik D, Chauvin-Kimoff L, Farion KJ, Ali S, Lynch T, et al. Practice variations in the treatment of febrile infants among pediatric emergency physicians. Pediatrics. 2009;124:439-45.
13. Yague A. [Variability in the prescription of antibiotics]. Enferm Infecc Microbiol Clin. 2002;20:78-84.
14. Comunicación sobre riesgos de medicamntos a profesionales sanitarios. Ref:2006/1,13 de marzo de 2006. Uso de asociación de Amoxicilina/Clavulánico y riesgo de hepatotoxicidad. (http://www.agemed. es/actividad/alertas/usoHumano/ seguridad/amoxiclavulanico.htm).
15. Metz-Gercek S, Maieron A, Strauss R, Wieninger P, Apfalter P, Mittermayer H. Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria. BMC Infect Dis. 2009;9:61, 61.
16. Goossens H, Ferech M, Vander SR, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87. (Pubitemid 40247914)
17. Van dS-B, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008;14:1722-30.
18. Barbaro-González A, Pastor-Sánchez R, del Arco-Ortiz de Zárate J, Eyaralar-Riera T, Espejo-Guerrero J. Demanda médica de medicamentos de prescripción sin receta médica. Aten Primaria. 2006;37:78-87. (Pubitemid 43363179)
19. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997 Aug 14;337(7):441-6. (Pubitemid 27333044)
20. Patrick DM, Hutchinson J. Antibiotic use and population ecology: how you can reduce your "resistance footprint". CMAJ. 2009;180:416-21.